Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Click to see more
Moderna, Inc. Details
Operating Status:Active
Business TypePublic
HeadquartersCambridge, Massachusetts, United States
Moderna’s booster shots combined with new COVID-19 vaccine variant is capable of creating more antibodies especially against the Brazilian and South African variant. Moderna will soon publish tests of its trials online. Besides, all eyes are on its earnings reports releasing later today.
The potential efficacy in the approved Pfizer-BioNTech and Moderna vaccines is spurring a delay in second dose administration by some nations, especially those with limited supplies of the jabs.
